Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 538 du 26 septembre 2022
Qualité de vie, soins de support (1)
Mené aux Etats-Unis sur 247 patientes ayant survécu à un cancer du sein (âge : moins de 50 ans), cet essai évalue l'effet de deux interventions sur la santé psychique, le stress et les marqueurs de l'inflammation
Improving biobehavioral health in younger breast cancer survivors: Pathways to Wellness trial secondary outcomes
Mené aux Etats-Unis sur 247 patientes ayant survécu à un cancer du sein (âge : moins de 50 ans), cet essai évalue l'effet de deux interventions sur la santé psychique, le stress et les marqueurs de l'inflammation
Improving biobehavioral health in younger breast cancer survivors: Pathways to Wellness trial secondary outcomes
Bower, Julienne E ; Partridge, Ann H ; Wolff, Antonio C ; Cole, Steve W ; Irwin, Michael R ; Thorner, Elissa D ; Joffe, Hadine ; Petersen, Laura ; Crespi, Catherine M ; Ganz, Patricia A
Background : The Pathways to Wellness trial tested the efficacy of two interventions for younger breast cancer survivors: mindful awareness practices (MAPs) and survivorship education (SE). This planned secondary analysis examines intervention effects on stress, positive psychological outcomes, and inflammation (Clincaltrials.gov NCT03025139). Methods : Women diagnosed with breast cancer at or before age 50 who had completed treatment and had elevated depressive symptoms were randomly assigned [...]
Observation (5)
Menée aux Etats-Unis à partir de données portant sur 2 089 enfants atteints d'un cancer, cette étude analyse l'association entre la pauvreté infantile et la survie
Persistent Child Poverty and Mortality in a Cohort of Children with Cancer in Alabama
Menée aux Etats-Unis à partir de données portant sur 2 089 enfants atteints d'un cancer, cette étude analyse l'association entre la pauvreté infantile et la survie
Persistent Child Poverty and Mortality in a Cohort of Children with Cancer in Alabama
Hoppmann, Anna L. ; Dai, Chen ; Daves, Marla ; Imran, Hamayun ; Whelan, Kimberly ; Kenzik, Kelly ; Bhatia, Smita
BACKGROUND: One fifth of US counties are designated persistent child poverty counties (>/=20% of children in poverty since 1980). The association between a persistent child poverty environment and mortality in children with cancer is unknown. METHODS: Our cohort includes 2,089 children with cancer (2000-2016) in Alabama. We used multivariable cox proportional hazards modeling (adjusted for sociodemographics/clinical characteristics) to assess mortality by persistent child poverty designation [...]
Menée au Royaume-Uni, cette étude analyse l'association entre les caractéristiques environnementales du voisinage (présence d'espaces verts, d'équipements sportifs, de boutiques d'alimentation à emporter, ...) et les disparités socioéconomiques dans les hospitalisations liées au cancer
Neighborhood environment and socioeconomic inequalities in cancer admissions: a prospective study using UK Biobank and linked hospital records
Menée au Royaume-Uni, cette étude analyse l'association entre les caractéristiques environnementales du voisinage (présence d'espaces verts, d'équipements sportifs, de boutiques d'alimentation à emporter, ...) et les disparités socioéconomiques dans les hospitalisations liées au cancer
Neighborhood environment and socioeconomic inequalities in cancer admissions: a prospective study using UK Biobank and linked hospital records
Mason, Kate E. ; Pearce, Neil ; Cummins, Steven
Purpose : Neighborhood environments may influence cancer risk. Average population effect estimates might mask differential effects by socioeconomic position. Improving neighborhood environments could inadvertently widen health inequalities if important differences are overlooked. Methods : Using linked records of hospital admissions in UK Biobank, we assessed associations between admission with a primary diagnosis of cancer (any/breast/colorectal), and exposure to neighborhood greenspace, [...]
Menée à partir de données portant sur 44 855 patientes atteintes d'un cancer du sein, cette étude analyse l'association entre l'utilisation d'anxiolytiques ou de sédatifs pendant une chimiothérapie adjuvante et la persistance de cette utilisation après le traitement anticancéreux
New and Persistent Sedative-Hypnotic Use after Adjuvant Chemotherapy for Breast Cancer
Menée à partir de données portant sur 44 855 patientes atteintes d'un cancer du sein, cette étude analyse l'association entre l'utilisation d'anxiolytiques ou de sédatifs pendant une chimiothérapie adjuvante et la persistance de cette utilisation après le traitement anticancéreux
New and Persistent Sedative-Hypnotic Use after Adjuvant Chemotherapy for Breast Cancer
Cogan, Jacob C ; Raghunathan, Rohit R ; Beauchemin, Melissa P ; Accordino, Melissa K ; Huang, Yongmei ; Elkin, Elena B ; Melamed, Alexander ; Wright, Jason D ; Hershman, Dawn L
Background : Sedative-hypnotic medications are used to treat chemotherapy-related nausea, anxiety and insomnia. However, prolonged sedative-hypnotic use can lead to dependence, misuse and increased healthcare utilization. We aimed to estimate the rates at which patients who receive adjuvant chemotherapy for breast cancer become new persistent users of sedative-hypnotic medications, specifically benzodiazepines and non-benzodiazepine sedative-hypnotics (Z-drugs). Methods : Using the MarketScan [...]
Menée auprès de 295 patientes atteintes d'un cancer du sein et âgées de plus de 65 ans, cette étude de cohorte prospective analyse l'association entre les niveaux de biomarqueurs de l'inflammation avant une chimiothérapie adjuvante et la dégradation de l'état du patient après le traitement
Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospectiv...
Menée auprès de 295 patientes atteintes d'un cancer du sein et âgées de plus de 65 ans, cette étude de cohorte prospective analyse l'association entre les niveaux de biomarqueurs de l'inflammation avant une chimiothérapie adjuvante et la dégradation de l'état du patient après le traitement
Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study
Jingran Ji ; Can-Lan Sun ; Harvey J. Cohen ; Timothy Synold ; Hyman Muss ; Mina S. Sedrak
PURPOSE : Older breast cancer survivors are at increased risk of clinical decline after adjuvant chemotherapy. This study aimed to evaluate whether inflammatory markers assessed before adjuvant chemotherapy are associated with chemotherapy-induced clinical decline in a population of fit older adults with breast cancer. METHODS : In a prospective study of women age ≥ 65 years with stage I-III breast cancer treated with chemotherapy, we measured interleukin-6 (IL-6) and C-reactive protein (CRP) [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Why the complications of COVID-19 patients differ in elderly and young cancer patients
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Why the complications of COVID-19 patients differ in elderly and young cancer patients
Bravaccini, Sara ; Nicolini, Fabio ; Zanoni, Michele ; Gaimari, Anna ; Cerchione, Claudio ; Maltoni, Roberta ; Pirini, Francesca ; Mazzotti, Lucia ; Cortesi, Michela ; Ravaioli, Sara ; Tumedei, Maria Maddalena ; Mazza, Massimiliano
Zhang et al. reported the impact of different risk factors and comorbidities in COVID-19 lethality. The authors observed that the odds of dying by COVID-19 in cancer patients decrease with age and cancer becomes a non-significant factor above 80 years. We speculate on the possible causes for the different COVID-19 severity between elderly and young patients. Several factors that can have a different impact on young and elderly have to be taken into account such as inflammation, microbiota and [...]
Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care
Ferrara, Pietro ; Dallagiacoma, Giulia ; Alberti, Federica ; Gentile, Leandro ; Bertuccio, Paola ; Odone, Anna
Worldwide, the COVID-19 pandemic disrupted healthcare services, including cervical cancer management, and an increased burden for this condition is expected. This systematic review synthetizes the available evidence on the impact of the pandemic on prevention, diagnosis and treatment of cervical cancer. Searches were performed on PubMed, Embase, and Scopus for relevant studies on these topics with the purpose of comparing service access and care delivery before and during COVID-19 pandemic. Due [...]
Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Os...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO)
Kajiwara Saito, Mari ; Morishima, Toshitaka ; Ma, Chaochen ; Koyama, Shihoko ; Miyashiro, Isao
Background : The coronavirus disease 2019 (COVID-19) affected cancer care in Japan, but the detailed impact on cancer diagnosis and treatment is not well-understood. We aimed to assess the impact of COVID-19 on digestive cancer care in Osaka Prefecture, which has a population of 8.8 million. Methods : We conducted a multi-center cohort study, using hospital-based cancer registry (HBCR) data linked to administrative data from 66 designated cancer care hospitals in Osaka. Records of patients [...]
Effects of the different periods and magnitude of COVID-19 infection spread on cancer operations: Interrupted time series analysis of medical claim...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Effects of the different periods and magnitude of COVID-19 infection spread on cancer operations: Interrupted time series analysis of medical claims data
Kashiwagura, Natsue ; Motoi, Fuyuhiko ; Cooray, Upul ; Fukase, Ryu ; Katayama, Yukiko ; Osaka, Ken ; Murakami, Masayasu ; Ikeda, Takaaki
Background : No clear evidence exists regarding the effects of the different periods and magnitude of spread of the COVID-19 infection on cancer treatments. This study investigated the effects of the different periods and magnitude of COVID-19 infection spread on in-hospital cancer operations. Methods : Medical claims data from 17 hospitals where in-hospital operations for patients with malignant neoplasms were performed between 1 April 2017 and 31 March 2021 in Yamagata were extracted and [...]
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer
Mair, Maximilian J. ; Mitterer, Manfred ; Gattinger, Pia ; Berger, Julia M. ; Valenta, Rudolf ; Fong, Dominic ; Preusser, Matthias
Patients with cancer are at high risk for severe COVID-19 and show impaired immune responses after vaccination. Specifically, levels of neutralizing antibodies against variants of concern, including Delta (B.1.617.2) and Omicron (B.1.1.529), are lower in patients with cancer than in those without. Fourth vaccination dose or administration of monoclonal neutralizing antibodies, such as tixagevimab and cilgavimab, is being considered, although data supporting this strategy are limited, especially [...]
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey
Pagano, Livio ; Salmanton-García, Jon ; Marchesi, Francesco ; Blennow, Ola ; Gomes Da Silva, Maria ; Glenthøj, Andreas ; van Doesum, Jaap A. ; Bilgin, Yavuz M ; Lopez-Garcia, Alberto ; Itri, Federico ; Nunes Rodrigues, Raquel ; Weinbergerová, Barbora ; Farina, Francesca ; Dragonetti, Giulia ; Berg Venemyr, Caroline ; Van Praet, Jens ; Jaksic, Ozren ; Valkovic, Toni ; Falces-Romero, Iker ; Martin-Perez, Sonia ; Jiménez, Moraima ; Davila-Valls, Julio ; Schonlein, Martin ; Ammatuna, Emanuele ; Meers, Stef ; Delia, Mario ; Stojanoski, Zlate ; Nordlander, Anna ; Lahmer, Tobias ; Pinczés, László Imre ; Buquicchio, Caterina ; Piukovics, Klára ; Ormazabal-Velez, Irati ; Fracchiolla, Nicola Stefano ; Samarkos, Michail ; Mendez, Gustavo-Adolfo ; Hernández-Rivas, José-Ángel ; Espigado, Ildefonso ; Cernan, Martin ; Petzer, Verena ; Lamure, Sylvain ; Di Blasi, Roberta ; Marques de Almeida, Joyce ; Dargenio, Michelina ; Biernat, Monika Maria, Dr ; Sciumè, Mariarita ; de Ramón, Cristina ; De Jonge, Nick Alexander ; Batinic, Josip ; Aujayeb, Avinash ; Marchetti, Monia ; Fouquet, Guillemette ; Fernández Escalada, Noemi ; Zambrotta, Giovanni Paolo Maria ; Sacchi, Maria Vittoria ; Guidetti, Anna ; Demirken, Fatih ; Prezioso, Lucia ; Racil, Zdenek ; Nucci, Marcio ; Mladenovic, Miloš ; Lievin, Raphaël ; Hanakova, Michaela ; Grafe, Stefanie K ; Sili, Uluhan ; Machado, Marina ; Cattaneo, Chiara ; Adzic-Vukicevic, Tatjana ; Verga, Luisa ; Labrador, Jorge ; Rahimli, Laman ; Bonanni, Matteo ; Passamonti, Francesco ; Pagliuca, Antonio ; Corradini, Paolo ; Hoenigl, Martin ; Koehler, Philipp ; Busca, Alessandro ; Cornely, Oliver A.
Limited data have been published on the epidemiology and outcomes of breakthrough COVID-19 in patients with hematological malignancy (HM) after anti-SARS-CoV-2 vaccination. Adult HM who received at least one dose of anti-SARS-CoV-2 vaccine and diagnosed with breakthrough COVID-19 between January 2021 and March 2022 and registered in EPICOVIDEHA were included in this analysis. A total of 1548 cases were included, mainly with lymphoid malignancies (1181 cases, 76%). After viral genome sequencing [...]
To investigate the internal association between SARS-CoV-2 infections and cancer through bioinformatics
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
To investigate the internal association between SARS-CoV-2 infections and cancer through bioinformatics
shen, Qinyan ; Wang, Jiang ; zhao, Liangying
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), also known as COVID-19, is currently prevalent worldwide and poses a significant threat to human health. Individuals with cancer may have an elevated risk for SARS-CoV-2 infections and adverse outcomes. Therefore, it is necessary to explore the internal relationship between these two diseases. In this study, transcriptome analyses were performed to detect mutual pathways and molecular biomarkers in three types of common cancers [...]
Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in India
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in India
Shetty, Omshree ; Shet, Tanuja ; Iyer, Ramya ; Gogte, Prachi ; Gurav, Mamta ; Joshi, Pradnya ; Karnik, Nupur ; Pai, Trupti ; Epari, Sridhar ; Desai, Sangeeta
Background : Molecular tests in solid tumours for targeted therapies call for the need to ensure precision testing. To accomplish this participation in the External Quality Assessment Program (EQAS) is required. This evaluates the consistency of diagnostic testing procedures and offers guidance for improving quality. Outbreak of COVID-19 pandemic led to worldwide lockdown and disruption of healthcare services including participation in EQAS.The present study describes the extended scope of EQAS [...]
Impact of COVID-19 and Socioeconomic Factors on Delays in High-Risk MRI Breast Cancer Screening
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Impact of COVID-19 and Socioeconomic Factors on Delays in High-Risk MRI Breast Cancer Screening
Teng, Helena ; Dang, Wilfred ; Curpen, Belinda
The purpose of this study is to investigate if there was a delay in high-risk MRI breast cancer screening in our local region, if this delay is ongoing despite COVID-19 vaccinations, and if demographic and socioeconomic factors are associated with these delays. Six-hundred and sixty-five high-risk breast patients from 23 January 2018–30 September 2021 were included. Delays were determined by comparing the time in between each patients’ MRI screening exams prior to the COVID-19 pandemic to the [...]
Approches psycho-sociales (2)
Menée en Australie par entretiens auprès de 24 hommes atteints d'un cancer localisé de la prostate à faible risque de récidive et de 12 partenaires de vie, cette étude identifie les facteurs socio-écologiques influençant leur prise de décision thérapeutique
Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancer
Menée en Australie par entretiens auprès de 24 hommes atteints d'un cancer localisé de la prostate à faible risque de récidive et de 12 partenaires de vie, cette étude identifie les facteurs socio-écologiques influençant leur prise de décision thérapeutique
Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancer
McIntosh, Megan ; Opozda, Melissa J. ; Short, Camille E. ; Galvão, Daniel A. ; Tutino, Rebecca ; Diefenbach, Michael ; Ehdaie, Behfar ; Nelson, Christian
Objective : Individuals diagnosed with low risk, localised prostate cancer (PCa) face a difficult decision between active surveillance (AS) and definitive treatment. We aimed to explore perceived influences on treatment decision-making from the patient and partner's perspectives. Methods : Patients (and partners) who met AS criteria and had chosen their treatment were recruited. Semi-structured individual interviews were conducted via telephone to explore experiences of diagnosis, impact on [...]
Menée au Liban à partir de données portant sur 112 patientes atteintes d'un cancer du sein traité par chimiothérapie (âge moyen : 56 ans), cette étude transversale analyse l'association entre des facteurs cliniques et génétiques et des déficiences cognitives auto-déclarées
Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the “CAGE-Cog” study
Menée au Liban à partir de données portant sur 112 patientes atteintes d'un cancer du sein traité par chimiothérapie (âge moyen : 56 ans), cette étude transversale analyse l'association entre des facteurs cliniques et génétiques et des déficiences cognitives auto-déclarées
Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the “CAGE-Cog” study
Hajj, Aline ; Khoury, Rita ; Hachem, Roula ; Awad, Aya ; Hallit, Souheil ; Sacre, Hala ; Nasr, Fady ; Karak, Fadi El ; Chahine, Georges ; Kattan, Joseph ; Khabbaz, Lydia Rabbaa
Background : Breast cancer patients undergoing chemotherapy treatment are at particular risk of experiencing acute cognitive impairment leading to daily challenges in decision-making and reduced quality of life and functional autonomy. The aim was to assess the relationship between clinical and genetic factors and cognitive function in a sample of patients with breast cancer undergoing chemotherapy. Methods : A cross-sectional study was carried out between November 2017 and June 2019 on women [...]
Soins palliatifs (2)
Menée au Japon auprès de 1 157 patients atteints d'un cancer de stade avancé et pris en charge dans des unités de soins palliatifs, cette étude de cohorte prospective identifie les facteurs associés à la "qualité du décès"
Factors associated with good death of patients with advanced cancer: a prospective study in Japan
Menée au Japon auprès de 1 157 patients atteints d'un cancer de stade avancé et pris en charge dans des unités de soins palliatifs, cette étude de cohorte prospective identifie les facteurs associés à la "qualité du décès"
Factors associated with good death of patients with advanced cancer: a prospective study in Japan
Ikari, Tomoo ; Hiratsuka, Yusuke ; Cheng, Shao-Yi ; Miyashita, Mitsunori ; Morita, Tatsuya ; Mori, Masanori ; Uneno, Yu ; Amano, Koji ; Uehara, Yuko ; Yamaguchi, Takashi ; Maeda, Isseki ; Inoue, Akira
Purpose : It is important for palliative care providers to identify what factors are associated with a “good death” for patients with advanced cancer. We aimed to identify factors associated with a “good death” evaluated by the Good Death Scale (GDS) score among inpatients with advanced cancer in palliative care units (PCUs) in Japan. Methods : The study is a sub-analysis of a multicenter prospective cohort study conducted in Japan. All variables were recorded on a structured data collecting [...]
Menée en Belgique par enquête auprès de 80 patients atteints d'un cancer incurable, cette étude transversale identifie les facteurs associés à leur intention de discuter avec leur médecin des soins palliatifs
Identification of the most important factors related to people with cancer starting a palliative care conversation: A survey study
Menée en Belgique par enquête auprès de 80 patients atteints d'un cancer incurable, cette étude transversale identifie les facteurs associés à leur intention de discuter avec leur médecin des soins palliatifs
Identification of the most important factors related to people with cancer starting a palliative care conversation: A survey study
Scherrens, Anne-Lore ; Beernaert, Kim ; Deliens, Luc ; Lapeire, Lore ; De Laat, Martine ; Biebuyck, Christine ; Geboes, Karen ; Van Praet, Charles ; Moors, Ine ; Deforche, Benedicte ; Cohen, Joachim
OBJECTIVE : A late conversation about palliative care needs can lead to suboptimal care in the final months/weeks of life. Insight into factors related to patients’ communication about palliative care is needed. This study aims to identify the factors associated with starting/intending to start a conversation about palliative care with the physician. METHODS : We performed a cross-sectional interviewer-administered survey among people with incurable cancer. Purposive sampling was used, taking [...]
Ressources et infrastructures (Lutte contre les cancers) (1)
Cette étude présente les recommandations de la "Society for Integrative Oncology" et de l'"American Society of Clinical Oncology" concernant les approches d'oncologie intégrative dans la prise en charge de la douleur des patients atteints d'un cancer
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
Cette étude présente les recommandations de la "Society for Integrative Oncology" et de l'"American Society of Clinical Oncology" concernant les approches d'oncologie intégrative dans la prise en charge de la douleur des patients atteints d'un cancer
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
Jun J. Mao ; Nofisat Ismaila ; Ting Bao ; Debra Barton ; Eran Ben-Arye ; Eric L. Garland ; Heather Greenlee ; Thomas Leblanc ; Richard T. Lee ; Ana Maria Lopez ; Charles Loprinzi ; Gary H. Lyman ; Jodi MacLeod ; Viraj A. Master ; Kavitha Ramchandran ; Lynne I. Wagner ; Eleanor M. Walker ; Deborah Watkins Bruner ; Claudia M. Witt ; Eduardo Bruera
PURPOSE : The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer. METHODS : The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature [...]